Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $1.9300 (1.58%) ($1.9300 - $1.9300) on Tue. May. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.27% (three month average) | RSI | 30 | Latest Price | $1.9300(1.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -3.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XME(96%) VYM(93%) KWEB(84%) IPO(99%) DRIV(95%) | Factors Impacting CGEN price | CGEN will decline at least -2.135% in a week (0% probabilities). UUP(-33%) SHY(-0%) XLU(7%) BNDX(12%) BND(16%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.135% (StdDev 4.27%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-15.96(-926.94%) | Resistance Level | $2.37 | 5 Day Moving Average | $2.12(-8.96%) | 10 Day Moving Average | $2.22(-13.06%) | 20 Day Moving Average | $2.37(-18.57%) | To recent high | -44.1% | To recent low | 1.6% | Market Cap | $160m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |